Eurofins Genomics Americas
Key Highlights
- Eurofins Genomics Americas offers a comprehensive suite of genomics services, including synthetic DNA, RNA oligos, and advanced sequencing technologies, making it a one-stop solution for genomic research and applications.
- The company leverages the global resources of the Eurofins Scientific group, providing clients with access to a vast network of laboratories and expertise across multiple countries.
- Eurofins Genomics Americas is committed to rapid turnaround times and high-quality results, ensuring that clients receive reliable and timely genomic data for their research and development needs.
- The company's focus on innovation and continuous improvement in its services and technologies positions it as a leader in the genomics industry.
- Eurofins Genomics Americas' strategic location in Louisville, Kentucky, allows it to serve a wide range of clients, from academic institutions to pharmaceutical companies, with its state-of-the-art genomic solutions.
About Eurofins Genomics Americas
Eurofins Genomics Americas is a leading provider of high-quality genomics products and services, offering synthetic DNA, specialized RNA oligos, gene synthesis, Sanger sequencing, and Nanopore sequencing. With a focus on rapid turnaround times and impeccable quality, Eurofins Genomics Americas serves a diverse range of clients, leveraging the extensive resources of the Eurofins Scientific group. The company operates from its headquarters in Louisville, Kentucky, and is part of a global network of over 180 laboratories in 35 countries.
Founded in 1987, Eurofins Genomics Americas has established itself as a trusted partner in the genomics industry, providing cutting-edge solutions for gene synthesis, sequencing, and other genomic services. The company's commitment to innovation and quality has made it a preferred choice for researchers and organizations worldwide.
As a public company, Eurofins Genomics Americas continues to expand its capabilities and services, driven by a mission to deliver the fastest and most reliable genomics solutions. The company's expertise in synthetic DNA, RNA oligos, and sequencing technologies positions it as a key player in the genomics market.
Leadership Team
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
Company Facts
| Ownership Private Company |
| Parent Company Eurofins Scientific |
Why Contact Eurofins Genomics Americas?
B2B professionals should contact Eurofins Genomics Americas for access to cutting-edge genomic technologies and services, enabling faster and more accurate research outcomes. The company's extensive experience and global network make it an ideal partner for organizations seeking reliable genomic solutions.
Who Should Contact Eurofins Genomics Americas for Business?
Sales teams targeting life sciences and pharmaceutical companies, research institutions, and academic labs should reach out to Eurofins Genomics Americas. The company's services are particularly valuable for those in need of high-quality genomic data and advanced sequencing technologies.
Categories
- genomics
- synthetic DNA
- RNA oligos
- gene synthesis
- Sanger sequencing
- Nanopore sequencing
- genomic research
- biotechnology
- pharmaceutical research
- genomic solutions
Frequently Asked Questions
- Who is the CEO of Eurofins Genomics Americas?
- Timothy S. Oostdyk serves as the Executive Vice President for BioPharma, Genomics and Agrosciences Services in North America.
- What is Timothy S. Oostdyk's email at Eurofins Genomics Americas?
- Timothy S. Oostdyk's email address is timothy.oostdyk@eurofinsgenomics.com.
- What does Eurofins Genomics Americas do?
- Eurofins Genomics Americas provides high-quality products and services in the genomics industry, including synthetic DNA (oligonucleotides), specialized long RNA oligos, and gene synthesis.
- How many employees does Eurofins Genomics Americas have?
- Eurofins Genomics Americas has approximately 55 employees.
- Where is Eurofins Genomics Americas headquartered?
- Louisville, Kentucky, United States of America
- What industry is Eurofins Genomics Americas in?
- Eurofins Genomics Americas operates in Genomics Services, Biotechnology, Pharmaceutical Research.
- When was Eurofins Genomics Americas founded?
- Eurofins Genomics Americas was founded in 1987.
- What is the email format at Eurofins Genomics Americas?
- Eurofins Genomics Americas uses the email format first.last@eurofinsgenomics.com.
- Is Eurofins Genomics Americas still active?
- Yes, Eurofins Genomics Americas was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to Eurofins Genomics Americas?
- Research Eurofins Genomics Americas's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to Eurofins Genomics Americas?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with Eurofins Genomics Americas